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Tail-anchored (TA) proteins are transmembrane polypeptides
characterized by an N-terminal functional cytosolic region anchored
to the lipid bilayer by a single transmembrane domain (TMD),
followed by a lumenal polar sequence no longer than 30 residues [1].
Bioinformatic analyses indicate that TA proteins are well represented
938 N. Borgese, E. Fasana / Biochimica et Biophysica Acta 1808 (2011) 937–946in all three domains of life, where they carry out a variety of essential
functions that beneﬁt from, or require, membrane anchorage, such as
membrane fusion in vesicular transport, protein translocation,
regulation of apoptosis, storage of transcription factors, and enzyme
catalysis [2–5].
Because the C-terminal TMD constitutes the only membrane-
targeting sequence and because it emerges from the ribosome
tunnel only after termination of translation, TA proteinsmust insert
into all their target membranes—endoplasmic reticulum (ER),
outer mitochondrial, outer chloroplast, peroxisomal, and prokary-
otic cytoplasmic membranes—by post-translational pathways.
Other, non-TA, membrane proteins of mitochondria, plastids and
peroxisomes also insert by post-translational mechanisms, how-
ever, proteins targeted to the ER- and the bacterial cytoplasmic
membrane generally use the co-translational pathwaymediated by
Signal Recognition Particle (SRP) [6]. TA proteins constitute a clear-
cut exception to this rule. The unique mechanisms by which the
members of this group of functionally important proteins achieve
their ﬁnal subcellular localization have recently attracted a great
deal of interest, and constitute the subject of this review.
A number of comprehensive review articles on TA proteins have
been published in the recent and less recent past [1,7–12], and the
reader is referred to these papers, as well as to the publications
reporting bioinformatic analyses [2–5,12], for detailed information on
the localization and functions of TA proteins in different organisms. In
this review, wewill focus on recent progress on TA protein biogenesis,
discussing unanswered questions and attempting to give a uniﬁed
picture of the general mechanisms underlying their targeting to—, and
integration into membranes.
As mentioned above, TA proteins can be inserted from the
eukaryotic cytosol into a number of target membranes, i.e., the ER,
the outer mitochondrial membrane (OMM), the Chloroplast Outer
Envelope (COE), and the peroxisomal membrane. Examples of TA
proteins speciﬁcally targeted to these different membranes are given
in Table 1. The ER represents themajor destination of TA proteins [3],
and from this initial insertion site many are then exported to
different compartments of the endo-membrane pathway (see
Table 1). We will ﬁrst discuss recent advances in our understanding
of insertionmechanisms of ER-targeted TA proteins, then summarize
what is known on their targeting to other organelles, and ﬁnally
attempt to give a conceptual framework in which to ﬁt our present
knowledge on TA protein targeting.Table 1
Examples of TA protein targeting.
Target membrane TA protein Function
ER Sec61β Protein tr
Ramp4 Protein tr
Synaptobrevin-2 SNARE re
vesicle ex
Sed5 Golgi SNA
of mamm
Cyt b5 Lipid met
OMM Small TOM proteins Protein tr
OMb5 Enzymatic
VAMP-1B SNARE of
Bcl-XL, Bak Regulation
COE A. thaliana cyt b5 isoform At1g26340 Enzymatic
Outer Envelope Membrane Protein 9 Unknown
Toc 33, 34 Protein tr
Peroxisomes Pex26 Peroxisom
Dual targeting: ER and OMM Bcl-2 Regulation
Dual targeting: OMM and peroxisomes Fis1 Mitochon
peroxisom2. Insertion of ER-targeted TA proteins
Although itwas realized early on that TAproteins are directed to the ER
only after their release from the ribosome, it was considered possible that
theymight translocate their C-terminus by post-translational engagement
of the Sec61 translocon. However, work with a number of substrates in
different systems (mammalian and yeast, the latter both in vivo and in
vitro) has excluded a role for Sec61 in TA protein transmembrane
integration [13–16]. It has instead become apparent that more than one
Sec61-independent pathway operates in ER targeting of TA substrates.
More speciﬁcally, in vitro studies have revealed the existence of an
unassisted pathway by which substrates with weakly hydrophobic TMDs
spontaneously integrate into the lipid bilayer, and chaperone-mediated,
energy-requiring pathways, by which most ER-targeted TA substrates
reach their destination.
2.1. Unassisted insertion of ER-targeted TA proteins
Mammalian cytochrome b5 (b5) is the most thoroughly investi-
gated ER TA protein capable of unassisted insertion. Early studies
indicated that puriﬁed b5 could associate with pure phospholipid
liposomes with a hairpin topology (N and C-terminus on the outside
of the vesicle; [17]). Much later, our laboratory, using stringent
proteolysis protection assays for bona ﬁde transmembrane integra-
tion of TA proteins, demonstrated that b5, translated in vitro in rabbit
reticulocyte lysate (RRL) translocates its C-terminus across pure lipid
bilayers as rapidly and as efﬁciently as across microsomal mem-
branes [16]. This work left open the possibility that chaperones of the
RRL might be required to keep b5 in an insertion competent form. To
investigate this possibility, we expressed b5 as fusion protein and
puriﬁed it free of chaperones. A complete lack of inﬂuence of RRL on
the extent and kinetics of transmembrane integration of this protein
into pure lipid vesicles demonstrated unequivocally that, at least in
vitro, b5 can translocate its C-terminus across the lipid bilayer in the
absence of any membrane or cytosolic protein, and that these do not
even facilitate the insertion process [18]. Interestingly, however, the
presence of even low concentrations of cholesterol in the vesicles
sharply inhibits the unassisted integration process [16].
Since it was known that other TA proteins do require ER membrane
protein(s) and energy for their insertion [13,19], we investigated what
feature of b5 is responsible for its capacity to insert without assistance.
Production of chimaeric proteins and mutagenesis experimentsNotes References
anslocation [23,25]
anslocation [26]
quired for synaptic
ocytosis
Also known as VAMP (Vesicle Associated
Membrane Protein)-2. Transported down the
secretory pathway from the ER to synaptic
vesicles in neuronal cells
[13]
RE (Yeast orthologue
alian syntaxin 5)
Transported from the ER to the Golgi complex [29]
abolism in the ER [62,74]
anslocation [73]
Mitochondrial isoform of cyt b5 [62,74]
unknown function Splicing variant of ER-targeted isoform (VAMP,
or synaptobrevin-1A)
[61]
of apoptosis [68]
[75]
[77]
anslocation [76,77]
e biogenesis [80]
of apoptosis [81]
drial and
al ﬁssion
[59]
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moderate hydrophobicity of the TMD [20]. Synaptobrevin 2 (Syb2) is a
well-known TA substrate incapable of unassisted insertion. Substitution
of Syb2's TMD with the one of b5 converted Syb2 into an unassisted
substrate, and conversely, b5was converted into an assisted substrate by
substituting its TMDwith the one of Syb2. Furthermore, point mutations
decreasingor increasingTMDhydrophobicityof Syb2andb5 respectively
favoured or inhibited their unassisted insertion, in agreement with the
conclusion that TMD hydrophobicity is the main determinant for access
to, or exclusion from, the unassisted pathway [20]. Finally, the
hydrophobicity hypothesis also proved to have a predictive value: two
ER-targeted TA proteins, one with TMD hydrophobicity close to the one
of b5 (Protein Tyrosine Phosphatase 1B—PTB-1B) and one with a more
hydrophobic TMD (Vesicle Associated Membrane Protein Associated
Protein-B—VAP-B) were analyzed and found to insert by the unassisted
and by an assisted pathway respectively, as expected [20,21].
Regardless of how unassisted proteins are targeted in vivo
(discussed in Section 4), the demonstration of efﬁcient spontaneous
transmembrane integration of TA proteins with moderately hydro-
phobic TMDs has implications for the understanding of the more
common assisted pathways. The requirement for chaperones for most
ER-targeted TA proteins is most likely related to the propensity of
hydrophobic sequences to aggregate in water, and also to the
difﬁculty for a hydrophobic sequence to cross the barrier of
phospholipid polar headgroups at the interface between the bilayer
and the surrounding aqueous phase. However, it is conceivable that
all TA proteins, once delivered to the appropriate membrane, can
translocate their C-terminus directly across the bilayer without the
need for any insertion machinery. In this view, the problem of TA
protein biogenesis is reduced to how the cell manages to deliver
different substrates to the correct target membrane in an insertion
competent form.
2.2. Chaperone-mediated pathways for ER-targeted TA proteins
Three chaperone-mediated pathways have been described so far
(reviewed in [11]): one mediated by SRP, functioning in an unusual
post-translational mode, one by the Hsc70/Hsp40 couple, and one by
a novel ATPase previously known as Asna1 (arsenical pump-driving
ATPase protein) in mammals and Arr4p in yeast. Following the
demonstration of its role in TA protein delivery to the ER, it was
renamed Transmembrane Recognition Complex subunit of 40 kDa
(TRC40) or Guided Entry of Tail-anchored proteins 3 (Get3) in
mammals and yeast, respectively.
The involvement of SRP and Hsc70/Hsp40 was suggested by
probing cross-linked adducts of TA substrates to RRL proteins with
antibodies against these chaperones. A facilitatory role of the
identiﬁed chaperones on insertion was then demonstrated using
truncated TA substrates released by puromycin from puriﬁed
ribosome-nascent chain complexes [22,23]. In addition, Hsc70 was
shown to interact with the TMD of a TA protein in plants, and to
facilitate its in vivo targeting to the nuclear envelope [24].
TRC40 was identiﬁed by unbiased examination of the interacting
partners of naturally terminated TA substrates [25,26]. Several
considerations indicate that the pathway mediated by this ATPase is
the most important one for targeting TA proteins to the ER. First,
cross-linking studied under a variety of conditions demonstrate that,
in vitro, TRC40 is the major cross-linking partner of a variety of TA
substrates (see [25], supplemental note for a discussion); second,
depletion of the SRP receptor from microsomal membranes is
generally without effect on TA protein insertion; furthermore
insertion is generally ATP- and not GTP-dependent [13,14,25], again
suggesting that SRP does not play an important role; third, in the RRL,
small molecule inhibition of the Hsp40/Hsc70 complex has no effect
on assisted TA substrates [27], indicating that these chaperones are
dispensable for insertion into the ER; in contrast, addition of anATPase-deﬁcient mutant of TRC40 to in vitro translation samples [25]
or antibody-mediated depletion of the ATPase from the RRL [18,28]
both strongly inhibit insertion of chaperone-requiring TA substrates;
ﬁnally, deletion of the yeast homologue Get3 has demonstrated the
importance of this ATPase in TA protein insertion in vivo [29]. We will
devote the remaining part of the section on ER-targeted TA proteins to
this novel chaperone system.
2.2.1. Discovery of the TRC40/Get pathway
TRC40 and Get3 are P-loop ATPases that belong to a family of
GTPases (named SIMBI for signal recognition particle, MinD and BioD),
some of which have acquired ATPase activity during evolution [30]. The
bacterial homologue, ArsA, is involved in heavy metal resistance [31],
and may, together with its membrane-embedded partner Ars B, effect
arsenite extrusion across the cytoplasmic membrane [32]. The eukary-
otic homologues, however, do not have an oxyanion binding site, and
their exact function remained unclear until recently.
As summarized in the ﬁrst paragraph of Section 2.2, biochemical
experiments carried out in the RRL by Stefanovic and Hegde [25] ﬁrst led
to the discovery of TRC40 as a chaperone that binds the TMD of TA
proteins and that plays a prominent role in TA protein biogenesis. In
mammals, deletion of TRC40 is embryonic lethal [33], suggesting that,
unless TRC40has someother yet unknown function, at least oneessential
TA protein critically depends on TRC40 for its targeting/insertion.
The work of Stefanovic and Hegde [25] was largely conﬁrmed by a
subsequent study [26], which, in addition, reported redox sensitivity
of the TRC40-dependent pathway. Both papers reported no, or very
weak association of the non-assisted substrate b5 with TRC40,
conﬁrmed by its insensitivity to dominant negative TRC40 [25] and
to TRC40 depletion [18].
In parallel with these studies in the mammalian system the Get3
pathway was characterized in yeast [29,34,35]. At variance with the
situation in mammals, Get3 (previously known as Arr4) is not an
essential gene in Saccharomyces, although its deletion confers
increased sensitivity to stress agents, such as heat or metals [36,37]
and causes defects in meiotic spore formation [38]. Based on a large-
scale genetic interaction map of the secretory pathway, obtained
through epistatic miniarray proﬁling of yeast deletion strains,
Schuldiner et al. [34] uncovered a strong interaction between get3
and two other genes, which were called get1 and 2, and conﬁrmed
previous work showing that the three gene products are physically
associated. Initially it was thought that the complex is involved in
retrograde transport from the Golgi complex to the ER (hence the
name, Golgi ER trafﬁcking 1–3). When the role of the mammalian
orthologue in TA protein targeting was discovered, an analogous
function of the Get 3 system was demonstrated in yeast both in vivo
and in vitro, and, accordingly, the meaning of the acronym was
changed to “Guided Entry of Tail-anchored proteins”. More speciﬁ-
cally, the following points were demonstrated: i) in agreement with
previous work [38], the transmembrane proteins Get1 and 2
constitute the ER receptor for Get3; ii) Get3 interacts with the TMD
of a number of ER-targeted TA proteins, which are in large part
displaced to the cytosol in the absence of Get3; iii) in the absence of
Get1/2, these TA proteins accumulate in cytosolic puncta which
contain Get3, indicating that the substrates remain trapped in an
unproductive complex with Get3; this phenotype correlates with the
aggravated growth defect of ΔGet1/2 strains in comparison with
strains in which all three of the Get proteins are absent; iv) Get
deletion causes severe impairment in translocation of the C-terminus
in in vitro translocation assays; v) in the absence of the Get complex, a
subset of ER-directed TA proteins mislocalize to the mitochondria,
suggesting that the Get pathway, in addition to a positive role in the
delivery of TA substrates to the ER, also hinders them from
inappropriate localization to alternative organelles; vi) ﬁnally, the
pleiotropic, and previously poorly understood, effects of get3 deletion
can each be explained by defective insertion of speciﬁc TA proteins.
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protein folding in the ER [35] or for retrieval of resident ER proteins
from the Golgi complex [39], two further genes—yor164c and mdy2—
that interact with get3 were identiﬁed, and accordingly renamed get4
and 5, respectively [35]. Get5/Mdy2 contains a ubiquitin-like-domain
(Ubl) and forms a complex with Get4. Get3 can be isolated from the
cytosol in a complex with Get4/5, and Δget5/Mdy2 strains have
similar defects in TA protein targeting as the strains deleted in the
other members of the pathway. Since Get4 and 5 have been found to
weakly associate with ribosomes [40], it was suggested they could
capture TA proteins upon their release from the ribosome and hand
them over to Get3 [35].
Recent biochemical studies in the mammalian system also support
the concept of a ribosome-associated complex acting upstream to
TRC40. Two groups [28,41] discovered an unexpected role for Bat3
(HLA-B associated transcript 3, also known as Scythe or Bag6), a
protein that contains an N-terminal Ubl, a nuclear localization
sequence, and a C-terminal BAG domain and that has been implicated
in a variety of biological processes (see Discussion in [28]). The ﬁrst
study [28] demonstrated that immunodepletion of Bat3 from the RRL
severely inhibits insertion of assisted substrates, but Bat3 alone is not
capable of supporting insertion in the absence of TRC40. Sucrose
gradient fractionation showed that complexes enriched in TRC40 are
more efﬁcient than those enriched in Bat3 in delivering a TA substrate
to the membrane, suggesting that Bat3 acts upstream to TRC40. The
second study [41] demonstrated that Bat3 exists in a complexwith the
mammalian homologues of Get4/5 (TRC35 and Ubl4A respectively),
and that it promotes binding of TA substrates to TRC40 after their
release from the ribosome. Very interestingly, the complex appears to
speciﬁcally recognize ribosomes that carry a TMD within the tunnel,
so that it is positioned to capture the substrate immediately upon its
release. In addition, the tail anchor in the ribosome tunnel slows the
process of chain termination, thus allowingmore time for recruitment
of Bat3/TRC45/Ubl4A. These ﬁndings might explain how the complex
can do its job, even if its intracellular concentration is much lower than
that of ribosomes. Indeed, in yeast, the number of copies of Get4 and 5
per cell are estimated at 5400 and 6500, respectively (Saccharomyces
Genome Database) in the face of ~300 000 ribosomes/cell. If the
complex were to randomly sample all ribosomes, the chances of its
being on the right ribosome at the right time would be extremely low.
Aﬁnal additional component, Sgt2, has recently been assigned to the
Get pathway in yeast. Sgt2 is a tetratricopeptide repeat-containing
protein, which interacts genetically and physically with Get4/5 [42–45].
This interaction involves Get5/Mdy2's Ubl domain. Sgt2 has a
mammalian homologue (SG2A; [46]), and also interacts with members
of the Hsp70 chaperone family. Deletion of Sgt2 in yeast causes a
mislocalization of the TA protein PEX15 similar to that observed when
Get3 is absent [44], however, its precise role in theGet pathway remains
to be elucidated [28,45].Table 2
Components of the Get/TRC40 pathway.
Protein Role in pathway
S. cerevisiae Mammals
Get3 TRC40 ATPase that binds the tran
Get1 Tryptophan Rich Basic Protein (WRB) Transmembrane protein
Receptor; a similar role f
Get2 – Transmembrane protein
Get3 Receptor.
Get4 Conserved Edge expressed protein (cee)/TRC35 Get4/5 complex is thoug
In mammals, it is associa
Get5/Mdy2 Ubl4A Ubl domain containing pro
to Get3. In mammals, it is
– Bat3 Ubiquitin-like and BAG d
Sgt2 SGTA Tetratricopeptide repeat p
protein biogenesis not unWhereas Get3–5 are conserved between yeast and mammals, this
is not the case for all components of the pathway. Notably, Bat3 does
not appear to have a yeast orthologue, and, vice versa, no mammalian
orthologue of Get2 has been identiﬁed, and the involvement of the
Get1 homologue (Tryptophan Rich Basic Protein, WRB) as TRC40
receptor on the ER has not been demonstrated. Strikingly, however, a
preformed complex between fungal Get3 and a mammalian TA
protein (Ramp4) is capable of efﬁciently releasing the substrate to
mammalian ER microsomes, indicating that the as yet undiscovered
mammalian receptor functionally interacts with the fungal chaperone
[47]. A summary of the components of the Get/TRC40 pathway so far
identiﬁed is provided in Table 2.
In summary, a considerable amount of work indicates that the
Get/TRC40 pathway plays a prominent role in TA protein targeting to
the ER. However, the ﬁnding that S. cerevisiae get genes are not
essential indicates that Get substrates do have salvage pathways by
which they can reach the ER. These could be provided by the non-
assisted (Section 2.1), and/or by the SRP andHsp40/Hsc70 (described
at the beginning of Section 2.2) pathways. The involvement of Hsp40
is suggested by the observation that in S. cerevisiae deletions of a
component of the Get pathway and of the Hsp40 protein YDJ1 are
more deleterious when combined than when present as single
mutations; this is to be expected if each of the two chaperone systems
can partially compensate for the loss of the other one [45].
2.2.2. Structural studies and models for the mechanism of Get3-mediated
insertion of TA proteins
Following the discovery of the role of TRC40/Get3 in TA protein
targeting, a lot of research has been aimed at unraveling themechanism
of action of this novel ATP-dependent chaperone, and in less than half a
year, ﬁve structural studies on Get3 have been published [47–51]. Based
on this structural information and on parallel biochemical experiments,
a number of models for the Get3 functional cycle have been proposed,
but at present it is difﬁcult to reconcile some of the conﬂicting data, and
exactly howGet3 couplesATPhydrolysis to TAbindingand release is not
yet clear.
The salient features that emerge from all the structural studies are:
i) Get3 exists as a homodimer. At the interface between the two
monomers, a zinc ion is coordinated by two Cys residues on each
monomer, to obtain a composite zincﬁnger: these twoCys residues are
essential for Get3 function; ii) each Get3 monomer is composed of an
ATPase domain, which contains all the features generally found in G-
type hydrolases, and an α-helical subdomain, which appears to be
highly dynamic, andwhich is unusually rich inMet residues.Mutational
and amide hydrogen exchange measurements indicate that this region
contains the TA binding site; conformational changes in this region
affect the activity of the ATPase domain, indicating that the two regions
are functionally linked; iii) different conformational states have been
captured in the ﬁve structural studies, categorized as completely closed,References
smembrane domain and delivers TA substrates to the ER membrane. [25,26,29]
of the ER. In Saccharomyces the Get1/2 complex constitutes the Get3
or the mammalian homologue has not been demonstrated.
[29]
of the ER. In Saccharomyces the Get1/2 complex constitutes the [29]
ht to deliver TA proteins from the ribosome to Get3.
ted with a third component, Bat3.
[35,39,41]
tein. Get4/5 complex is thought to deliver TA proteins from the ribosome
associated with a third component, Bat3.
[35,39,41]
omain containing protein. Acts upstream to TRC40. [28,41]
eptide-containing protein that interacts with Get4/5. Precise role in TA
derstood.
[43–45]
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point centered on the coordinated zinc ion. The completely closed
conformation is seen in the ADP-AlF4-bound protein that represents the
transition state primed for ATPhydrolysis [48]. The closed conformation
is seen in both the pre-hydrolysis (AMPPNP-Mg2+) and the post-
hydrolysis (ADP-Mg2+) states [47]. Open conformations are observed in
the nucleotide-free state or in the proteinwith bound ADP but noMg2+
[48,49,51].
In the completely closed conformation (ADP-AlF4-bound), the two
subunits present a largedimer interface surface area; the rearrangement
of the α-helical subdomain results in the generation of a composite
hydrophobic groove that most likely provides a binding site for the TA
and which appears well suited to accommodate a hydrophobic stretch
of ~20 residues, as found in many ER-targeted TA proteins (Fig. 1). The
abundance of methionine residues within the groove recalls a similar
feature in the M (signal peptide binding) domain of SRP54 and may
contribute to the ability of Get3 to accommodate diverse tail anchors. In
the open conformation, the two subunits are splayed apart so that a
large cleft is interposed between the twoα-helical subdomains and the
composite hydrophobic groove is disrupted (Fig. 1). In the closed
(AMPPNP-Mg2+ or ADP-Mg2+-bound) state, the hydrophobic groove
observed in the ADP-AlF4-bound protein is not fully assembled.
From these studies it appears that ATP hydrolysis is possible only
when the TA cargo is bound. However, how TA binding and release
and ATP hydrolysis are coordinated is still unclear. Initially, it was
thought that release to the membrane is triggered by ATP hydrolysis
[52]. However, this model is not compatible with recent studies, in
which a TA substrate was expressed in E. coli together with Get3
[47,51] or TRC40 [53]. A nucleotide-free complex containing the
chaperone and its bound substrate could be isolated from the bacterial
lysate. Subsequent release of the substrate to ER microsomes was
triggered by ATP, but also, to a lower, but still considerable extent, by
ADP and by a non-hydrolysable ATP analogue. In consideration ofFig. 1. Closed and open states of Get3 dimer. A and B show the open (nucleotide-free) and closed
and negatively charged residues are in blue and red, respectively. The dimensions of the com
permission from [48].these data, and of the ﬁnding that the ADP-Mg2+ structure is closed,
Bozkurt et al. [47] proposed that the ATP hydrolysis step is required
for the release of Get3 from its membrane receptor rather than for
delivery of the TA substrate to the bilayer. The situation is further
complicated by the report of an open, nucleotide-free, conformation
of Get3 that presents a possible TA binding site ([50,51]; Fig. 2), and by
the isolation of complexes between a bacterially co-expressed TA
substrate and ATPase-deﬁcient Get3 mutants [51]. It should be kept in
mind that complex formation between overexpressed proteins in the
bacterial cytosol may not be reﬂecting events occurring under
physiological conditions. This caveat is reasonable, also considering
that, in yeast, TA delivery to Get3 depends on the presence of Get4/5
and these proteins were not co-expressed in the experiments in
bacteria. Four differentmodels that have been proposed for Get3/ATP-
driven insertion of TA proteins are depicted in Fig. 2.
There is also work in progress on the Get4/5 complex. Three crystal
structures of Get4 have been published so far [45,54,55]. In two of these
structures [45,55], Get4 is in a complexwith the N-terminal fragment of
Get5/Mdy2. Get 4 is an elongated protein, composed of 14 pairwise
arranged α-helices (α-solenoid fold) and an additional α-helix close to
the C-terminus. A combination of structural, physicochemical, and
biochemical studies indicate that the Get4/5 complex exists as a
homodimer [55] and that each Get4 molecule forms a bridge between
Get5/Mdy2 and Get3. These associate with Get4's C- and N-terminal
regions, respectively. Get3 binding is stimulated by addition of ADP or
ATP, suggesting that it binds in the closed state, and adding complexity
to the role of the ATP hydrolysis cycle in TA protein targeting [55]. The
Get5/Mdy2 structure, apart from the N-terminal domain in complex
with Get4 has not been resolved yet. However, mutational analysis
indicates that its C-terminaldomain is responsible forhomodimerization
of the complex [55]. Intriguingly, the N-terminal domain of Get5/Mdy2
that interacts with Get4 is not present in the mammalian homologue,
Ubl4A. Perhaps the presence of Bat3 in the mammalian complex(ADP-AlF4-bound) state, respectively. Hydrophobic residues are colored green; positively
posite hydrophobic groove are indicated on the right side of panel B. Reproduced with
Fig. 2. Four different models for the Get3 functional cycle. Models depicted in [44,45,47,48] have been redrawn in a uniform style. The Get3 dimer is in green, and the Get3 receptor at
the ER is in two shades of brown. The red diamond indicates a Zinc ion. T and D indicate the presence of bound ATP or ADP, respectively. A: ATP and TA binding are coupled, and ATP
hydrolysis, triggered upon membrane binding of the complex, is required for release of the TA to the bilayer [48]. B: Binding of TA-Get3 can occur with either ATP or ADP bound. ATP
hydrolysis and release of phosphate is required for recycling of the Get3 dimer from the membrane to the cytosol [47]. C: The TA can bind to the open dimer, and ATP stabilizes the
binding by inducing the closed state. ATP hydrolysis and engagement of the Get3 receptor are followed by release of ADP with return of Get3 to the open state and integration of the
TA in the membrane [50]. D: Binding of the TA occurs to the Get dimer in the absence of bound nucleotide. ATP binds after engagement of the Get3 receptor, and release of the TA
depends on ATP hydrolysis [51].
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homologues. Finally, it must be mentioned that putative ribosome and
TA binding sites, predicted by the hypothesis that the Get4/5 complex
captures tail anchors at the exit of the ribosomal tunnel, have not been
identiﬁed so far.
3. Insertion into other organelles
3.1. Peroxisomes
Whereas targeting to the ER membrane occurs via machinery
dedicated to TA proteins, investigations carried out up till now on
peroxisomal TAproteins, indicate that theyare inserted by amechanism
common to the post-translational insertion of other class I peroxisomal
membrane proteins. Class I peroxisomal proteins depend on the import
receptor Pex19. Pex19 binds its newly synthesized substrates in the
cytosol and, byassociatingwith itsmembrane integrated receptor, Pex3,
delivers them to the peroxisomal membrane ([56], but see also [57]).
Halbach et al. [58] identiﬁed two Pex19 recognition sequences in the
TMD and lumenal sequence of the mammalian TA protein Pex26, and
demonstrated that the interaction between these sequences and Pex19
is required for delivery of Pex26 to peroxisomes. In the absence of the
lumenal recognition sequence, Pex26 was inappropriately delivered to
mitochondria [58]. Similar Pex19 recognition sequenceswere identiﬁed
also in yeast Pex15, a TAprotein thought to be the functional orthologue
of mammalian Pex26 [58]. The interpretation of the data for the yeastprotein is however complicated by the ﬁnding that its distribution is
shifted to mitochondria in Δ□□□□□ yeast cells, suggesting that, as is
the case for a large number of yeast peroxisomal membrane proteins
[57] it normally reaches peroxisomes by membrane trafﬁc, after
insertion into the ER by the Get-dependent pathway [29].
Another TA protein whose targeting to peroxisomes has been
studied is the ﬁssion protein Fis1. Human Fis1 localizes mainly to
mitochondria but a small amount also targets the peroxisomes. As in
the case of Pex26, delivery to peroxisomes is Pex19-dependent [59].
The recognition sequence for Pex19 is at the extreme C-terminus and
is not required for mitochondrial targeting. It will be interesting to see
whether the Pex19-dependence is conﬁrmed for other peroxisomal
TA proteins.
3.2. Mitochondria
TA protein delivery to the Outer Mitochondrial Membrane (OMM)
appears to depend on physico-chemical features of the tails rather
than on deﬁned signals. Whereas the ER targeting machinery can
accommodate a large variety of TA lengths, hydrophobicity and
ﬂanking charges, TA proteins targeted to the OMM are generally
characterized by TMDs of moderate hydrophobicity. In mammals, this
moderately hydrophobic TMD is usually ﬂanked on one or both sides
by positive charges. Mutagenesis studies on selected OMM proteins
carrying these features have demonstrated that both are essential for
correct targeting, and altering either one of them causes rerouting of
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previous review [9], however, although these features on the average
clearly distinguish the population of mitochondrially targeted tails
from their ER counterparts, and although deletion of these properties
by site directed mutation results in loss of correct targeting, there is
quite some overlap in hydrophobicity and positive charge between
OMM and ER TA proteins. Thus, these features alone cannot explain
speciﬁc in vivo targeting. An additional TMD feature reported to favor
mitochondrial targeting is the propensity for α-helix formation [66].
The generality of this interesting observation deserves to be tested on
a larger number of artiﬁcial and natural sequences with different
targeting speciﬁcity.
In fungi and plants, the presence of ﬂanking positive charges does
not distinguish OMM from ER-targeted TA proteins, and moderate
hydrophobicity seems to be the only clear hallmark for OMM targeting
[2,4]. This may explain why mammalian OMM TA proteins are not
always faithfully targeted in the yeast system (our unpublished results,
see also [67]).
Investigations on the nature of the machinery responsible for TA
protein targeting to the OMM have yielded conﬂicting results. Recent
work has excluded the participation of the Translocase of the Outer
Membrane (TOM) machinery in insertion of three different TA
substrates (Bak, BclXL, and OMP25) in semi-intact mammalian cells
[68] and of the yeast mitochondrial ﬁssion protein Fis1 in vitro [65]. On
the other hand, TOM20 has been implicated in the import of Bcl-2
[64,69], while TOM22 has been identiﬁed as the receptor for the
proapoptoic TA protein Bax [70]. In the latter case, the targeting signal is
contained in the N-terminal domain of Bax. Similarly, increased
targeting of Bcl-2 was reported to be mediated by the interaction of
its N-terminal domain with an OMM-localized binding partner (FKB35;
[71]). TOM22 itself has been considered a TA protein (although its polar
C-terminal domain of 41 residues exceeds the deﬁning length of 30
residues), and found to depend on both TOM20 and TOM70 for its
import [72]. Very interestingly, the β-barrel-speciﬁc sorting and
assembly machinery/topogenesis of β-barrel proteins (SAM/TOB)
complex facilitates integration of TOM22 into the OMM [73]. All these
results suggest that TA proteins may be targeted to mitochondria by
more than one mechanism.
Part of thedifﬁculty in investigatingTA targeting to theOMMderives
from the moderately hydrophobic nature of the TMD of most
mitochondrial TA proteins. This feature predicts that many of them
should be able to insert into lipid bilayers without assistance, and,
indeed, insertion into protein-free bilayers has been demonstrated for
Fis1 [65], for a mitochondrially targeted isoform of b5 (our unpublished
results), and for Bcl-2 [19]. This unassisted insertion in vitro may mask
speciﬁc, chaperone-mediated targeting occurring in vivo. An example of
this problem is given by our studies on the targeting of the two b5
isoforms, which are speciﬁcally localized to the OMM and the ER [74].
Mutation of the C-terminal polar domain of the ER targeted protein to
contain a net positive charge results in a protein (b5-RR) that is
speciﬁcally targeted to mitochondria in vivo. Yet, in vitro, this mutant
inserts into ER microsomes as efﬁciently as its wild-type counterpart
[62].Mitochondria added to the translocation reaction competewith ER
microsomes, and sequester the TA substrate to the OMM. However, this
competition is as efﬁcient for the mitochondrial as for the ER-targeted
substrate (our unpublished results), illustrating how the speciﬁc in vivo
targeting of the two b5 isoforms is not recapitulated in vitro.
3.3. Plastids
TA protein targeting to plastids has been investigated for a
Chloroplast Outer Envelope (COE) isoform of cyt b5 [75], for the GTPase
import receptors Toc33 and 34 [76,77] and for a COE protein (OEP9) of
unknown function [77].
The Arabidopsis genome contains ﬁve putative cyt b5 isoforms, all
with a net positive charge at the C-terminus [12]. One of these isoforms(AtCb5-3) is sorted to the ER and another (AtCb5-6) to the COE [75]. In
cells lacking chloroplasts, the latter is targeted to the OMM [75],
illustrating once again that mitochondria represent a common des-
tination for TA proteins when their normal targeting pathway is
nonfunctional. Not clariﬁed is the basis for the COE isoform's preference
for theCOEunder normal conditions, nor for thediscrimination between
the ER and the COE of the two investigated isoforms. The TMDs of both
have similarﬂankingpositive charges, however, hydrophobicity analysis
reveals that the ER-targeted TMD is slightly more hydrophobic than its
COE-targeted counterpart. Whether this difference explains the speciﬁc
targeting of the two isoforms remains to be established.
More mechanistic insight was obtained from the investigations on
the other three COE proteins [76,77], which revealed that OEM9 and
Toc 33/34 partially differ in their targeting mechanism. Targeting
determinants of OEM9 are, as is generally true for TA proteins, entirely
contained in the tail region. In contrast, Toc33 and 34 targeting
depends also on information within the N-terminal GTPase domain.
Insertion of both proteins into chloroplasts was enhanced by proteins
exposed on the surface of the COE, however, only Toc33 and 34
insertion was facilitated by their own presence in the membrane.
Furthermore, the effect of lipid composition on the association of
Toc33/34 and OEM9 to protein-free liposomes was different. Very
interestingly, however, both OEM9 and Toc33/34 interact with
Arabidopsis Ankyrin Repeat Protein-2A (AKR2A), a chaperone
recently demonstrated to be involved in targeting of COE proteins
[78]. Thus, as is the case for peroxisomes, targeting of TA proteins to
plastids may depend on chaperones involved in the post-translational
insertion of other, non-TA, COE proteins.
4. The targeting problem: A ﬁerce competition between chaperones
The demonstration that some TA proteins can translocate their C-
terminus across protein-free bilayers [16,20,65,76] suggests that also
those which require chaperone-mediated assistance may in the ﬁnal
step spontaneously integrate into the bilayer. For this reason,webelieve
that speciﬁc targeting, rather than translocation, constitutes the major,
incompletely solved problem in the ﬁeld of TA protein biogenesis.
Membranes of the secretory pathway downstream to the ER are
nonpermissive for TA protein insertion. This nonpermissivity is at
least in part due to lipid composition, notably, to sterol content
[16,65]. Therefore, in animal and fungal cells, there are only three
possible target membranes for newly synthesized TA proteins: the ER,
peroxisomes and the OMM. A fourth target, the plastid outer
envelope, is present in plant cells.
The discovery of the Get3/TRC40 pathway has represented a major
breakthrough for our understanding of TA protein targeting. The
presence of a speciﬁc Get3 receptor (Get1/2) on the ER membrane
nicely accounts for Get3-mediated targeting to the ER, and it is
presumed that a functional homologue on the ER of higher eukaryotes
plays the same role. Nevertheless, the speciﬁc targeting to the ER of TA
proteins that are able to insert in the absence of TRC40/Get3, such as
b5 and PTB1B [18,20], remains mysterious. It is possible that in vivo
these proteins do associate with Get3/TRC40, as suggested by the
formation of a stable complex between b5 and TRC40 when the two
proteins are expressed together in E. coli [53]. Another possibility is
that yet other unidentiﬁed chaperones are involved, as suggested by
our recent work [18]. Whatever the targeting factors are, they must in
the case of the unassisted TA proteins have a dual role, preventing
inappropriate spontaneous insertion into all permissive bilayers while
favouring delivery to the correct target.
TA proteins targeted to peroxisomes, the OMM, and the COE must
avoid binding Get3/TRC40. On the one hand, theymay have low afﬁnity
for this chaperone, as suggested by the observation that the composite
hydrophobic groove of Get3 is of sufﬁcient length to host longer TMDs
than those normally present in TA proteins targeted to organelles other
than the ER. Furthermore, the extremities of the groove are rich in basic
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charges, as found in mammalian OMM TA proteins [48]. On the other
hand, they may have stronger afﬁnity for other targeting factors which
deliver them to the appropriate destination. This appears to be the case
for the peroxisomal TA proteins that depend on PEX19 [58,59], and it
may turn out that AKR2A has a similar function for plastid-targeted TA
proteins [77].
This leaves out the OMM, for which the targeting factors still remain
mysterious. It might be speculated that targeting to the ER, to
peroxisomes and to plastids is signal-mediated, and that the OMM
represents the default pathway for TA protein insertion, i.e., any TA
protein without targeting information for other organelles will insert
into the OMM. We ﬁnd this hypothesis unlikely, because (i) in the
absence of the Get pathway in Saccharomyces not all ER TA proteins are
mislocalized tomitochondria [29], suggesting that features additional to
lack of Get3 binding are required for mitochondrial targeting; and (ii) in
vitro at least some OMM proteins are capable of integrating into ER
microsomes [62,65], hence in vivo these proteins must interact with
factors that hinder their inappropriate insertion into the ER.While these
factors await identiﬁcation, we speculate that Hsc70/Hsp40 may play a
role in mitochondrial targeting. In vitro, in the complete RRL system,
these chaperones interactwith ER-targeted TAproteinswithmoderately
hydrophobic TMDs (b5, PTB-1B, and Bcl-2), andnotwith classical TRC40
substrates [27]. It could be that in vivo theHsc70 system is out-competed
by TRC40 in the case of ER-targeted TA proteins, even of those with
weakly hydrophobic TMDs, but that it does win in the competition for
mitochondrial TA proteins. This hypothesis is attractive because the
OMM import receptor TOM70 has been recognized as a binding partner
of Hsp70. TheHsp70/TOM70 interaction functions in thedelivery of a set
of mitochondrial precursor proteins to the mitochondrion for subse-
quent import [79].
Other speciﬁcity factors may contribute to the fate of newly
synthesized TA proteins. For instance, in addition to the effects of sterols,
additional differences in lipid composition of the target membranes
could inﬂuence targeting, a point that deserves further investigation.Fig. 3. Simpliﬁed scheme illustrating how competition between chaperones may govern T
interact with many different chaperones. Chaperones that mediate insertion into the ER, O
arrows pointing away or towards each chaperone represent kon (upper arrow) and koff (low
length of each arrow is proportional to the postulated rate constants. The most rapidly and st
conditions (e.g., depletion of one chaperone system), alternative fates for a given TA prote
particular chaperone system, but is presented only as a general framework. The choice of t
proteins doubly localized to ER and OMM, as well as to OMM and peroxisomes have beenAdditional possibilities that might be considered are pre-translational
targeting phenomena, i.e., localization of mRNA's coding for differently
localized TA proteins in close proximity to the target organelle, or post-
insertion phenomena, i.e., initial indiscriminate insertion of a TA protein
into all permissive membranes, followed by its rapid degradation in the
inappropriate organelle. At least for b5, we can exclude these two
mechanisms, because:ﬁrst,microinjectedb5protein is correctly targeted
to the ER in cultured cells [18], indicating that the targeting information
is in theprotein andnot in themRNA; second, in S. cerevisiae, b5 carrying
an epitope with a consensus for N-glycosylation, is completely
glycosylated after a pulse of only 5 min, indicating that it is all in the
ER [20]. It is unlikely that in this short time span, the protein could be
inserted into other membranes and then be completely degraded.
Because of the above considerations, we favor the idea that
competition between chaperones, possibly in conjunction with differ-
ences in bilayer lipid composition, underlies the complexities of TA
protein targeting. As schematized in Fig. 3, upon release from the
ribosome, TA proteins presumably encounter a number of potential
chaperones. Different on and off rates of the interactionsmay determine
which chaperone system, and hence which target membrane, wins out
in the competition. Subtle sequence differences and changes in the
availability of different chaperone systemsmay alter the outcome of the
competition, resulting in some cases in dual targeting (Table 1), and
explaining why some ER TA proteins are re-directed to the OMM in the
absence of the Get system. This non-univocal mode of targetingmay be
exquisitely amenable to regulation, and we can expect examples of this
to be discovered in the future.
5. Conclusions
The increased interest in TA proteins and the development of
appropriate assays to investigate their membrane integration has led
to great progress in our understanding of the biogenesis of this class of
proteins. Notably, the discovery of a novel chaperone system (Get3/
TRC40) has generated a lot of excitement. TA protein biogenesis hasA protein targeting. The cartoon illustrates how different TA proteins can potentially
MM and peroxisomal membrane are in red, blue, and green respectively. The colored
er arrow) rate constants of that chaperone for a given TA substrate. The thickness and
ably binding chaperone will determine the TA substrate's destination, but under altered
in are possible. The cartoon is not meant to illustrate the exact mode of action of any
he relative on and off rates has been made in consideration of the observation that TA
described (Table 1), but none are known to be shared by the ER and peroxisomes.
945N. Borgese, E. Fasana / Biochimica et Biophysica Acta 1808 (2011) 937–946proven to present more intricacies that had perhaps been anticipated.
Thus, notwithstanding the recent progress, we still have a lot to learn,
and can anticipate new unexpected developments during the next
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